584 related articles for article (PubMed ID: 27226065)
21. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
Nishikawa M; Miyake H; Fujisawa M
Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
[TBL] [Abstract][Full Text] [Related]
22. Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy.
Lee H; Kim YJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kwak C; Kim HH; Oh JJ; Lee SC; Hong SK; Lee SE; Byun SS;
BMC Cancer; 2017 May; 17(1):364. PubMed ID: 28545466
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
Huang H; Wang XP; Li XH; Chen H; Zheng X; Lin JH; Kang T; Zhang L; Chen PS
BMC Cancer; 2017 Aug; 17(1):544. PubMed ID: 28806937
[TBL] [Abstract][Full Text] [Related]
24. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
Chang X; Zhang F; Liu T; Wang W; Guo H
Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
[TBL] [Abstract][Full Text] [Related]
26. Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.
Takenaka Y; Takemoto N; Yasui T; Yamamoto Y; Uno A; Miyabe H; Ashida N; Shimizu K; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Cho H; Yamamoto M; Inohara H
PLoS One; 2016; 11(10):e0164057. PubMed ID: 27732629
[TBL] [Abstract][Full Text] [Related]
27. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
28. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
Zinellu A; Arru F; De Vito A; Sassu A; Valdes G; Scano V; Zinellu E; Perra R; Madeddu G; Carru C; Pirina P; Mangoni AA; Babudieri S; Fois AG
Eur J Clin Invest; 2021 Jan; 51(1):e13427. PubMed ID: 33043447
[TBL] [Abstract][Full Text] [Related]
29. Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis.
Brookman-May S; May M; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Feciche B; Coman I; Truss M; Pahernik S; Wirth MP; Zastrow S; Dalpiaz O; Fenske F; Waidelich R; Stief C; Gunia S;
Clin Genitourin Cancer; 2013 Dec; 11(4):465-70. PubMed ID: 23820063
[TBL] [Abstract][Full Text] [Related]
30. Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.
Obata J; Tanaka N; Mizuno R; Kanao K; Mikami S; Matsumoto K; Kosaka T; Kikuchi E; Jinzaki M; Oya M
BJU Int; 2016 Oct; 118(4):598-603. PubMed ID: 26780664
[TBL] [Abstract][Full Text] [Related]
31. The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Scheipner L; Smolle MA; Barth D; Posch F; Stotz M; Pichler M; StÖger H; Gerger A; Riedl JM
Anticancer Res; 2021 Jan; 41(1):429-436. PubMed ID: 33419840
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.
Mori K; Janisch F; Mostafaei H; Kimura S; Lysenko I; Karakiewicz PI; Briganti A; Enikeev DV; Rouprêt M; Margulis V; Chlosta P; Nyirady P; Babjuk M; Egawa S; Shariat SF
Urol Oncol; 2020 Jun; 38(6):601.e17-601.e24. PubMed ID: 32127252
[TBL] [Abstract][Full Text] [Related]
33. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
[TBL] [Abstract][Full Text] [Related]
34. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
35. The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer.
Knittelfelder O; Delago D; Jakse G; Reinisch S; Partl R; Stranzl-Lawatsch H; Renner W; Langsenlehner T
Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33228184
[TBL] [Abstract][Full Text] [Related]
36. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy.
Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ
J Endourol; 2017 Apr; 31(4):397-404. PubMed ID: 28121179
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
38. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
